MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy

Max Gelman

Senior Editor

A small-cap biotech developing gene therapies is spinning out its Parkinson’s disease program into a new company in partnership with a secretive AI startup co …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy

Max Gelman

Senior Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Updated: White House pulls Weldon's nomination to lead CDC at last minute

Trump blog: FDA, NIH picks clear Senate panel; FDA top lawyer resigns

Acelyrin, Pliant turn to ‘poison pill’ as Kevin Tang’s Concentra pursues both companies

Updated: Endo and Mallinckrodt to merge in $6.7B deal

Amgen reports more Uplizna data in myasthenia gravis ahead of FDA filing

Obesity drug development—still room to grow

MeiraGTx teams with cryp­tic AI start­up, co-found­ed by Er­ic Schmidt, to ad­vance Parkin­son's gene ther­a­py

Senior Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

MeiraGTx teams with cryptic AI startup, co-founded by Eric Schmidt, to advance Parkinson's gene therapy